Adverse Event Reporting News - Tegretol carries risk of serious skin conditions in Asian patients
January 11th, 2009 Novartis Pharmaceuticals Canada, following discussion with Health Canada, has revised its Product Monograph for Tegretol (carbamazepine) to include in the WARNINGS section information about the risks of Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), particularly in patients of Asian descent.
Both conditions involve serious and sometimes fatal dermatologic reactions. The risk of SJS and TEN exists in all patients, but these reactions are genera…
Exceptional Parent, The - Anticonvulsant syndrome
January 9th, 2009I have a 4-year-old boy who may have anticonvulsant syndrome as a result of Tegretol, a medication I had to take during the last two trimesters of my pregnancy to prevent seizures. I am hoping to find someone who knows more about this rare syndrome and what more I can do to help my son. He is developmentally delayed, although is steadil…
Pediatrics for Parents - Birth defects and Tegretol
January 4th, 2009Birth Defects and Tegretol
Carbamazepine (Tegretol) is used to treat many medical problems. The list includes epilepsy, bipolar depression, excited psychosis, alcohol withdrawal, and trigeminal neuralgia (facial pain). But what if a woman …
Adverse Event Reporting News - Tegretol USP, chewable tablets, and oral suspension
December 29th, 2008 Tegretol-XR (carbamazepine extendedrelease tablets)
BOXED WARNING
Serious Dermatologic Reactions and HLA-B*1502 Allele
Serious and sometimes fatal dermatologic reactions, including toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), have been reported during treatment with Tegretol. These reactions are estimated to occur in 1 to 6 per 10,000 new users in c…
Business Wire - Tegretol®-XR receives clearance for marketing
December 24th, 2008SUMMIT, N.J.–(HealthWire)–May 2, 1996–Ciba-Geigy Corp. announced today that Tegretol(R)-XR (carbamazepine extended-release tablets), the first extended release anti-epileptic drug, recently received U.S. Food and Drug Administration clearance for marketing.
“Tegretol is a me…
FDA Requires Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic Medications
December 19th, 2008ROCKVILLE, Md., Dec. 16, 2008-The U.S. Food and Drug Administration today announced it will require the manufacturers of antiepileptic drugs to add to these products’ prescribing information, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). The action includes all antiepileptic drugs including thos…
Fda Generic Medication Approval Method Adequacy
December 16th, 2008The FDA applies a rigid rule of what they call bioequivalence trying to make sure that generic medications are identical medicine with equal effects as the original one. When measured in the laboratory and in the simple, small trials with humans, a generic drug must deliver similar active component in the blood of patient virtually similar amount to almost the same proportion as the original medication.
The Food and Drug Administration…
Epilepsy – Symptoms , Causes and Treatment
December 12th, 2008Epilepsy is a common chronic neurological disorder that is characterized by recurrent unprovoked seizures.[1][2] These seizures are transient signs and/or symptoms due to abnormal, excessive or synchronous neuronal activity in the brain.[3] About 50 …
Treating Multiple Sclerosis Pain - Anticonvulsants & New Frontiers in Treatment
December 6th, 2008 For the most part, however, acute MS pain can’t be effectively treated with
aspirin, ibuprofen, or other common OTC pain reliever medications or
treatments. “Since most MS pain originates in the central nervous system,
it makes it a lot more difficult to control than joint or muscle pain,”
says Kathleen Hawker, MD, an assistant professor of neurology in the multiple
sclerosis program at the University of Texas Southwestern Medical Center in
Dallas (UTSW).
So what’s the …
Fabry Disease – Causes and Symptoms of Fabry Disease
December 4th, 2008Fabry disease is one of several genetically inherited diseases called lysosomal storage disorders. It causes a wide range of signs and symptoms that can range from mild to severe and life threatening. This site connects the Fabry community to information about the causes, diagnosis and management of Fabry disease. The site also provides support to patients, families, and healthcare providers….

